Definium Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Definium Therapeutics Inc
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a best-in-class care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company also continues to advance its early-stage pipeline, having dosed the first patient in a Phase 2a study of DT4023 in adults with autism spectrum disorder (ASD).
/ 
Others were interested in
Frequently asked questions
To buy Definium Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Definium Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Definium Therapeutics Inc is DFTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Definium Therapeutics Inc has its primary listing on NASDAQ (Small cap). You can trade Definium Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Definium Therapeutics Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Definium Therapeutics Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Definium Therapeutics Inc.